Median Technologies Names Oran Muduroglu President of U.S. Subsidiary Median eyonis Inc

Reuters
Feb 19
Median Technologies Names Oran Muduroglu President of U.S. Subsidiary Median eyonis Inc

Median Technologies SA has appointed Oran Muduroglu as President of Median eyonis Inc., its U.S. subsidiary, to lead the U.S. launch and scale-up of the eyonis® LCS lung cancer screening software. Median eyonis Inc. is expanding U.S. commercial and clinical support teams and will pursue a phased national rollout, including distribution partnerships such as a non-exclusive agreement with Tempus AI to integrate eyonis® LCS into Tempus’ Pixel platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260218440005) on February 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10